JoshuaRyanRichterMD

PubMed

• 36 citations
  Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra
  Shashidhar S. Jatiani, Adolfo Aleman, Deepu Madduri, Ajai Chari, Hearn Jay Cho
  Clinical Lymphoma, Myeloma & Leukemia. 2020-05-11
• 34 citations
  Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.
  Sherry Bhalla, David Melnekoff, Adolfo Aleman, Violetta V. Leshchenko, Paula Restrepo
  Science Advances. 2021-11-19
• 59 citations
  Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
  Noopur S Raje, Elias Anaissie, Shaji K Kumar, Sagar Lonial, Thomas Martin
  The Lancet. Haematology. 2022-02-01

Abstracts/Posters

• A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma
  Joshua R Richter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
  Joshua Richter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• ADAR1 Drives Disease Progression in Multiple Myeloma By Acting Both As an RNA Editor of Specific Transcripts and As a DNA Mutator of Their Cognate Genes
  Joshua Richter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase 1, multicenter, open-label study of single-agent bispecific antibody t-cell engager GBR 1342 in relapsed/refractory multiple myeloma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018